Delivery Order SPE2DB20D2104-SPE2DB24FMCHJ
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $2,208.53 and an ultimate completion date of August 21, 2024. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts to provide a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed price of $6,065.75 and a completion date of March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,773.94 firm fixed-price contract is for the delivery of 4 mg Ondansetron hydrochloride tablets, a medication commonly used to prevent nausea and vomiting. The contract has a completion date of November 3, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,713.47 and a period of performance through April 30, 2024. The contract is for the procurement of ondansetron hydrochloride 4 mg tablets, a medication used to prevent nausea and vomiting. This contract is not associated with a set-aside program. The contract is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Ondansetron Hydrochloride 4 mg tablets, a medication used to prevent nausea and vomiting, with a ceiling value of $9,006.97 and a completion date of September 12, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a ceiling value of $24,582.83 and a completion date of July 3, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Ondansetron HCL 4 mg tablets, a generic pharmaceutical product used to treat nausea and vomiting. The delivery order has a ceiling value of $6,170.70 and a completion date of September 9, 2024. The contract is a firm fixed price arrangement. AmerisourceBergen, one of the largest pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $1,304.72 and a completion date of August 15, 2024. This contract is not set aside for any specific business type. AmerisourceBergen has been awarded numerous federal contracts by defense and civilian...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...